adham jurdi, md | ctdna and mrd testing with the expanded access program
Published 4 years ago • 170 plays • Length 9:00
Download video MP4
Download video MP3
Similar videos
-
1:16
adham jurdi, md | different options when it comes to mrd testing from a ctdna standpoint
-
1:55
adham jurdi, md | expanded access programs during covid19
-
2:57
adham jurdi, md | patient case using ctdna and mrd testing
-
5:34
farshid dayyani, md | ctdna and mrd testing with the expanded access program
-
2:59
adham jurdi, md | importance of ctdna and mrd testing
-
1:51
a positive ctdna test after adjuvant therapy: 2023 best of gi
-
7:44
sanjay r. jain, mb, ms, md, phd | ctdna and mrd testing with the expanded access program
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference
-
35:43
hematologist oncologist (cancer doctor) interview | day in the life, hematology oncology residency
-
58:52
ctdna and mrd | 2023 best of gi cancer conference
-
22:31
sarcoma
-
1:08
adham jurdi, md | importance of surveillance during covid-19
-
1:02
ctdna testing for mrd – reliable, sensitive, and specific, but challenges remain: 2022 esmo florida
-
2:58
urmeel patel, md | signatera, expanded access programs, and surveillance
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
2:01
farshid dayyani, md | what is signatera?
-
4:26
fundamentals of ctdna
-
1:43
axel grothey, md | what is signatera?
-
2:25
jairus ibabao, md | medical oncology and hematology
-
0:45
the emerging role of ctdna in cancer diagnostics
-
2:33
linking the diagnosis-to-treatment interval with ctdna
Clip.africa.com - Privacy-policy